These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36079137)

  • 41. Mortality risk factors in patients with Acinetobacter baumannii ventilator: associated pneumonia.
    Chang HC; Chen YC; Lin MC; Liu SF; Chung YH; Su MC; Fang WF; Tseng CC; Lie CH; Huang KT; Wang CC
    J Formos Med Assoc; 2011 Sep; 110(9):564-71. PubMed ID: 21930066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colistin-Resistant
    Papathanakos G; Andrianopoulos I; Papathanasiou A; Priavali E; Koulenti D; Koulouras V
    Microorganisms; 2020 Feb; 8(2):. PubMed ID: 32093299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A two-year retrospective study of multidrug-resistant Acinetobacter baumannii respiratory infections in critically Ill patients: Clinical and microbiological findings.
    Hafiz TA; Alghamdi SS; Mubaraki MA; Alghamdi SSM; Alothaybi A; Aldawood E; Alotaibi F
    J Infect Public Health; 2023 Mar; 16(3):313-319. PubMed ID: 36641839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
    Karruli A; Boccia F; Gagliardi M; Patauner F; Ursi MP; Sommese P; De Rosa R; Murino P; Ruocco G; Corcione A; Andini R; Zampino R; Durante-Mangoni E
    Microb Drug Resist; 2021 Sep; 27(9):1167-1175. PubMed ID: 33600262
    [No Abstract]   [Full Text] [Related]  

  • 45. Risk factors for carbapenem-resistant
    Cogliati Dezza F; Covino S; Petrucci F; Sacco F; Viscido A; Gavaruzzi F; Ceccarelli G; Raponi G; Borrazzo C; Alessandri F; Mastroianni CM; Venditti M; Oliva A
    JAC Antimicrob Resist; 2023 Aug; 5(4):dlad096. PubMed ID: 37577156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics and Outcomes of Acinetobacter baumannii Infections in Critically Ill Patients with Cancer: A Matched Case-Control Study.
    Nazer LH; Kharabsheh A; Rimawi D; Mubarak S; Hawari F
    Microb Drug Resist; 2015 Oct; 21(5):556-61. PubMed ID: 26430944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventilator-associated Pneumonia: Multidrug Resistant Acinetobacter vs. Extended Spectrum Beta Lactamase-producing Klebsiella.
    Salehi M; Jafari S; Ghafouri L; Malekafzali Ardakani H; Abdollahi A; Beigmohammadi MT; Dehghan Manshadi SA; Feizabadi MM; Ramezani M; Abtahi H; Seifi A
    J Infect Dev Ctries; 2020 Jun; 14(6):660-663. PubMed ID: 32683358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of Multidrug-Resistant
    Alenazi TA; Shaman MSB; Suliman DM; Alanazi TA; Altawalbeh SM; Alshareef H; Lahreche DI; Al-Azzam S; Araydah M; Karasneh R; Rebahi F; Alharbi MH; Aldeyab MA
    Healthcare (Basel); 2023 Feb; 11(4):. PubMed ID: 36833021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology and infection control of carbapenem resistant Acinetobacter baumannii and Klebsiella pneumoniae at a German university hospital: a retrospective study of 5 years (2015-2019).
    Chhatwal P; Ebadi E; Schwab F; Ziesing S; Vonberg RP; Simon N; Gerbel S; Schlüter D; Bange FC; Baier C
    BMC Infect Dis; 2021 Nov; 21(1):1196. PubMed ID: 34837973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit.
    Munier AL; Biard L; Legrand M; Rousseau C; Lafaurie M; Donay JL; Flicoteaux R; Mebazaa A; Mimoun M; Molina JM
    Int J Infect Dis; 2019 Feb; 79():179-184. PubMed ID: 30529108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
    Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K
    Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
    Huang X; Li G; Yi L; Li M; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Nutman A; Temkin E; Wullfhart L; Schechner V; Schwaber MJ; Carmeli Y
    Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37764022
    [No Abstract]   [Full Text] [Related]  

  • 54. Nomogram for predicting 90-day mortality in patients with
    Pei Y; Huang Y; Pan X; Yao Z; Chen C; Zhong A; Xing Y; Qian B; Minhua S; Zhou T
    J Int Med Res; 2023 Mar; 51(3):3000605231161481. PubMed ID: 36935582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk Factors and Impact on Clinical Outcome of Multidrug-Resistant Acinetobacter Baumannii Acquisition in Cardiac Surgery Patients.
    Pierri MD; Crescenzi G; Capestro F; Recanatini C; Manso E; D'errico MM; Prospero E; Barbadoro P; Torracca L
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):680-6. PubMed ID: 26718661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia.
    Deng Y; Chen L; Yue M; Huang X; Yang Y; Yu H
    BMC Infect Dis; 2022 Oct; 22(1):795. PubMed ID: 36271362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of environmental cleaning on the colonization and infection rates of multidrug-resistant Acinetobacter baumannii in patients within the intensive care unit in a tertiary hospital.
    Li Y; Ge H; Zhou H; Zhou W; Zheng J; Chen W; Cao X
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):4. PubMed ID: 33407899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multi-drug resistant Acinetobacter species: a seven-year experience from a tertiary care center in Lebanon.
    Kanafani ZA; Zahreddine N; Tayyar R; Sfeir J; Araj GF; Matar GM; Kanj SS
    Antimicrob Resist Infect Control; 2018; 7():9. PubMed ID: 29387343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
    Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
    J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.